NCT01961063View on ClinicalTrials.gov

Gene Therapy After Frontline Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

August 28, 2025

Study Completion Date

August 28, 2025

Conditions
AIDS-related Non-Hodgkin LymphomaAIDS-related Plasmablastic LymphomaAIDS-related Primary Effusion LymphomaHIV Infection
Interventions
DRUG

busulfan

Given IV

BIOLOGICAL

lentivirus vector rHIV7-shI-TAR-CCR5RZ-transduced hematopoietic progenitor cells

Given IV

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
lead

City of Hope Medical Center

OTHER